EMCDDA news

New report provides window onto EU drug market changes during COVID-19

What effect is COVID-19 having on the largest criminal market in the EU? This question is explored in EU Drug Markets: Impact of COVID-19, a new report out today from the EU drugs agency (EMCDDA) and Europol (1). The analysis reports higher prices, local shortages and reduced purity for some drugs, while noting continued violence among suppliers and distributors. It also shows how organised crime groups remain active and resilient, by ‘adapting transportation models, trafficking routes and concealment methods’, even during the pandemic.
Read more

Testing for drug-related infectious diseases — a crucial step towards meeting international health goals

Testing for drug-related infectious diseases among people who inject drugs (PWID) is crucial if international health targets are to be met. This is among the conclusions of a new EMCDDA report out today: Drug-related infectious diseases in Europe. The update, from the agency’s drug-related infectious disease network, stresses that early diagnosis through testing, and improving links to treatment and care, are crucial steps towards reaching global health goals.
Read more

COVID-19: New EMCDDA study highlights drop in availability of drug services in Europe but increase in innovation

As Europe grapples with the unprecedented public health threat posed by COVID-19, how is the outbreak affecting drug users and service providers? In a new study published today — Impact of COVID-19 on drug services and help-seeking in Europe — the EMCDDA reports signs of a drop in the availability of drug services during the pandemic and in the numbers of those seeking help. But the study also provides insight into how services have adapted and innovated during the fast-changing crisis in ways that could be carried forward into the future.
Read more

Increase in darknet market activity for cannabis as users stock up for lockdown

The COVID-19 pandemic has profoundly impacted on our daily lives, including our behaviour as consumers. Just as we have seen online shopping for other goods increase during lockdowns, will we see a similar shift when it comes to illicit drugs? In a special report out today, Drug supply via darknet markets, the EMCDDA explores whether established methods of drug supply and distribution to consumers have changed during recent restrictions on movement.
Read more